Skip to Main content Skip to Navigation
Journal articles

CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma

Abstract : Melanoma cell phenotype switching between differentiated melanocytic and undifferentiated mesenchymal-like states drives metastasis and drug resistance. CDK7 is the serine/threonine kinase of the basal transcription factor TFIIH. We show that dedifferentiation of melanocytic-type melanoma cells into mesenchymal-like cells and acquisition of tolerance to targeted therapies is achieved through chronic inhibition of CDK7. In addition to emergence of a mesenchymal-type signature, we identify a GATA6-dependent gene expression program comprising genes such as AMIGO2 or ABCG2 involved in melanoma survival or targeted drug tolerance, respectively. Mechanistically, we show that CDK7 drives expression of the melanocyte lineage transcription factor MITF that in turn binds to an intronic region of GATA6 to repress its expression in melanocytic-type cells. We show that GATA6 expression is activated in MITF-low melanoma cells of patient-derived xenografts. Taken together, our data show how the poorly characterized repressive function of MITF in melanoma participates in a molecular cascade regulating activation of a transcriptional program involved in survival and drug resistance in melanoma.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03336903
Contributor : Frédéric Coin Connect in order to contact the contributor
Submitted on : Tuesday, September 7, 2021 - 2:08:34 PM
Last modification on : Wednesday, September 8, 2021 - 3:27:45 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Pietro Berico, Max Cigrang, Guillaume Davidson, Cathy Braun, Jeremy Sandoz, et al.. CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma. EMBO Reports, EMBO Press, 2021, 22 (9), pp.e51683. ⟨10.15252/embr.202051683⟩. ⟨inserm-03336903⟩

Share

Metrics

Record views

35